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Abstract— Virtual Screening (VS) methods can considerably 
aid clinical research, predicting how ligands interact with drug 
targets. Most VS methods suppose a unique binding site for the 
target, but it has been demonstrated that diverse ligands interact 
with unrelated parts of the target and many VS methods do not 
take into account this relevant fact. This problem is circumvented 
by a novel VS methodology named BINDSURF that scans the 
whole protein surface to find new hotspots, where ligands might 
potentially interact with, and which is implemented in  massively 
parallel Graphics Processing Units, allowing fast processing of 
large ligand databases. BINDSURF can thus be used in drug 
discovery, drug design, drug repurposing and therefore helps 
considerably in clinical research. However, the accuracy of most 
VS methods is constrained by limitations in the scoring function 
that describes biomolecular interactions, and even nowadays 
these uncertainties are not completely understood. In order to 
solve this problem, we propose a novel approach where neural 
networks are trained with databases of known active (drugs) and 
inactive compounds, and later used to improve VS predictions. 
I. INTRODUCTION  
In clinical research, it is crucial to determine the safety and 
effectiveness of current drugs and to accelerate and active 
compounds into meaningful health outcomes. Both objectives 
need to process the large data set of protein structures available 
in biological databases such as PDB [1] and also derived from 
genomic data using techniques as homology modeling [2]. 
Screenings in lab and compound optimization are expensive 
and slow methods, but Bioinformatics can vastly help clinical 
research for the mentioned purposes by providing prediction of 
the toxicity of drugs and activity in non-tested targets and by 
evolving discovered active compounds into drugs for the 
clinical trials. 
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This can be achieved thanks to the availability of 
Bioinformatics tools and Virtual Screening (VS) methods that 
allow testing all required hypothesis before clinical trials. 
Nevertheless current Virtual Screening (VS) methods, such as 
docking, fail to make good toxicity and activity predictions 
since they are constrained by the access to computational 
resources; even the nowadays-fastest VS methods cannot 
process large biological databases in a reasonable time frame. 
Therefore, these constraints impose serious limitations in many 
areas of translational research. 
The use of massively parallel and throughput-oriented 
hardware architectures such as Graphics Processing Units 
(GPUs) can tremendously overcome this problem. The GPU 
has become increasingly popular in the High Performance 
Computing (HPC) arena, by combining impressive 
computational power with the demanding requirements of real-
time graphics and the lucrative mass-market of the gaming 
industry [3]. Scientists have exploited this power in arguably 
every computational domain, and the GPU has emerged as a 
key resource in applications where parallelism is the common 
denominator [4]. To maintain this momentum, new hardware 
features have been progressively added by NVIDIA to their 
range of GPUs, with the Kepler architecture [5] being the most 
recent milestone in this path. Therefore, GPUs are well suited 
to overcome the lack of computational resources in VS 
methods, accelerating the required calculations and allowing 
the introduction of improvements in the biophysical models not 
affordable in the past [6]. We have previously worked in this 
direction, showing how VS methods can benefit from the use 
of GPUs [7-9]. Moreover, another important lack of VS 
methods is that they usually take the assumption that the 
binding site derived from a single crystal structure will be the 
same for different ligands, while it has been shown that this 
does not always happen [10], and thus it is crucial to avoid this 
very basic supposition. In this work, we present a novel VS 
methodology called BINDSURF, which takes advantage of 
massively parallel and high arithmetic intensity of GPUs to 
speed-up the required calculations in low cost and consumption 
desktop machines, providing new and useful information about 
targets and thus improving key toxicity and activity 
predictions. In BINDSURF a large ligand database is screened 
against the target protein over its whole surface simultaneously. 
Afterwards, information obtained about novel potential protein 
hotspots is used to perform more detailed calculations using 
any particular VS method, but just for a reduced and selected 
set of ligands. 
Other authors have also performed VS studies over whole 
protein surfaces [11] using different approaches and screening 
small ligand databases, but as far as we know, none of them 
have been implemented on GPUs and used in the same fashion 
as BINDSURF. 
However, the accuracy of most VS methods is constrained 
by limitations in the scoring function that describes 
biomolecular interactions, and even nowadays these 
uncertainties are not completely understood. In this paper we 
tackle with this problem, proposing a novel approach where 
neural networks are trained with databases of known active 
(drugs) and inactive compounds and later used to improve VS 
predictions through BINDSURF. 
The rest of the paper is organized as follows. Section II 
briefly introduces the preliminary knowledge to better 
understand the rest of the article. Section III we introduce our 
proposal of training neural networks to improve VS predictions 
before concluding the paper and showing possible directions 
for future work.  
II. METHODOLOGY  
In this section we describe the methodologies we used for 
the prediction of protein-ligand affinity; a) the Virtual 
Screening method BINDSURF, and b) a neural network trained 
with chemical similarity data of known active and inactive 
compounds. 
A. Virtual Screening with BINDSURF 
The main idea underlying our VS method BINDSURF is 
the protein surface screening method, implemented in parallel 
on GPUs. Essentially, VS methods screen a large database of 
molecules in order to find which one fit some established 
criteria [12]. In the case of the discovery of new leads, 
compound optimization, toxicity evaluation and additional 
stages of the drug discovery process, we screen a large 
compound database to find a small molecule, which interacts in 
a desired way with one or many different receptors. Among the 
many available VS methods for this purpose we decided to use 
protein-ligand docking [13, 14]. These methods try to obtain 
rapid and accurate predictions of the 3D conformation a ligand 
adopts when it interacts with a given protein target, and also the 
strength of this union, in terms of its scoring function value. 
Docking simulations are typically carried out in a very concrete 
part of the protein surface in methods like Autodock [15], 
Glide [16] and DOCK [17], to name a few. This region is 
commonly derived from the position of a particular ligand in 
the crystal structure, or from the crystal structure of the protein 
without any ligand. The former can be performed when the 
protein is co-crystallized with the ligand, but it might happen 
that no crystal structure of this ligand-protein pair is at disposal. 
Nevertheless, the main problem is to take the assumption, once 
the binding site is specified, that many different ligands will 
interact with the protein in the same region, discarding 
completely the other areas of the protein. 
Given this problem, we propose to overcome it by dividing 
the whole protein surface into defined regions. Next, docking 
simulations for each ligand are performed simultaneously in all 
the specified protein spots. Following this approach, new 
hotspots might be found after the examination of the 
distribution of scoring function values over the entire protein 
surface. This information could lead to the discovery of novel 
binding sites. If we compare this approach with a typical 
docking simulation performed only in a region of the surface, 
the main drawback of this approach lies on its increased 
computational cost. We decided to pursue in this direction and 
show how this limitation can be overcome thanks to GPU 
hardware and new algorithmic designs. 
In essence, in a docking simulation we calculate the ligand-
protein interaction energy for a given starting configuration of 
the system, which is represented by a scoring function [18]. In 
BINDSURF the scoring function calculates electrostatic (ES), 
Van der Waals (VDW) and hydrogen bond (HBOND) terms. 
Furthermore, in docking methods it is normally assumed 
[12] that the minima of the scoring function, among all ligand-
protein conformations, will accurately represent the 
conformation the system adopts when the ligand binds to the 
protein. Thus, when the simulation starts, we try to minimize 
the value of the scoring function by continuously performing 
random or predefined perturbations of the system, calculating 
for each step the new value of the scoring function, and 
accepting it or not following different approaches like the 
Monte Carlo minimization method [19] or others. Simulations 
were always carried out with a total of 500 Monte Carlo steps. 
For a detailed discussion it is advisable to have a look at our 
previous BINSURF publication [20]. 
B.  Neural Networks 
One of the most dominant application areas of neural 
networks is non-linear function approximation. There are 
several types of feed-forward neural networks; the most widely 
used being multi-layer networks with sigmoidal activation 
functions (multi-layer perceptrons) and single layer networks 
with local activation functions (radial basis function networks). 
The good approximation capability of neural networks has 
been widely demonstrated by both practical applications and 
theoretical research. We decided to use a single-hidden-layer 
neural network with skip-layer connections (see Figure 1) in 
this study since it has been clearly demonstrated its impact on 
chemical applications concerning similarity calculations [21].  
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Single hidden layer neural network structure. 
For such purpose we used the nnet function of the R 
package [22]. The following default parameters described in 
Table 1 were used.  
TABLE 1. MOST RELEVANT PARAMETERS USED FOR THE NEURAL NETWORK 
USED IN THE NNET FUNCTION OF THE R PACKAGE. 
 
Parameter value 
WeighDecayFactor 0.001 
CrossValidationFolds 5 
MaxNumberIterations 2000 
MaxnumberWeights 2000 
TraceOptiimization no 
 
C. Molecular similarity 
Extended-connectivity fingerprints (ECFPs), which are 
implemented in jCompoundMapper [23] were used as 
structural descriptors for training the Neural Networks. The 
ECFPs are a class of fingerprints for molecular 
characterization. Its features correspond to the presence of an 
exact structure (not a substructure) with limited specified 
attachment points. 
In generating the fingerprints, the program assigns an initial 
code to each atom. The initial atom code is derived from the 
number of connections to the atom, the element type, atomic 
charge, and atomic mass. This corresponds to an ECFP with a 
neighborhood size of zero. These atom codes are then updated 
in an iterative manner to reflect the codes of each atoms 
neighbors. In the next iteration, a hashing scheme is employed 
to incorporate information from each atom immediate 
neighbors. Each atoms new code, now describes a molecular 
structure with a neighborhood size of one. This process is 
carried out for all atoms in the molecule. When the desired 
neighborhood size is reached, the process is complete and the 
set of all features is returned as the fingerprint. For the ECFPs 
employed in this paper, neighborhood sizes of two, four and six 
(ECFP 2, ECFP 4, ECFP 6) were used to generate the 
fingerprints. The resulting ECFPs can represent a much larger 
set of features than other fingerprints and contain a significant 
number of different structural units crucial for the molecular 
comparison, among the compounds. 
III. RESULTS AND DISCUSSION 
A. Virtual Screening with BINDSURF 
We performed VS calculations with BINDSURF using 
standard benchmark tests, such as the Directory of Useful 
Decoys (DUD) [24], where VS methods check how efficient 
they are in differentiating ligands that are known to bind to a 
given target, from non-binders or decoys. Input data for each 
molecule of each set contains its molecular structure and 
whether it is active or not. After BINDSURF calculations, 
results for three different DUD datasets are shown in the ROC 
curves of Figure 2. Given the results obtained for the DUD 
datasets TK, MR and GPB, and characterized by the value of 
the area under the curve (AUC) for each ROC curve, it could 
be said that, on average, BINDSURF performs similarly than 
other docking methods reported for these datasets [25]. 
Fig. 2. ROC plots obtained using BINDSURF for the targets of the DUD data 
set TK (red), MR (blue) and GPB (green). Diagonal line indicates random 
performance. Obtained values for AUC are 0.700, 0.695 and 0.675, 
respectively. 
Nevertheless, it is clear that there is still room for 
improvement in the scoring function that BINDSURF uses, and 
in its energy optimization method (Monte Carlo), since both 
affect directly to the effectiveness of the direct prediction of 
binding poses. 
Fig. 3. ROC plots obtained using a neural network for the targets of the DUD 
data set TK (green), MR (blue) and GPB (red). Diagonal line indicates 
random performance. Obtained values for AUC are 0.801, 0.812 and 0.963, 
respectively. 
 
B. Neural Networks based activity prediction based on 
chemical similarity 
Neural networks were trained with the previously 
mentioned DUD datasets TK, MR and GPB and also using 
ECFP 2, ECFP 4, ECFP 6 fingerprints; which were calculated 
for each molecule as described in the methods section. 
Different combinations of these parameters were tested (only 
ECFP 2, ECFP 2 plus ECFP 4, etc) and we observed that using 
simultaneously the three descriptors yielded the best results in 
terms of AUC for the ROC curves, as can be seen in Figure 3. 
If we compare these results with the previous ones obtained 
by BINDSURF in Figure 2 it is clear that predictive capability 
increases. 
Consequently, and taking into account information obtained 
by the neural network we can post-process docking results 
obtained by the scoring function of BINDSURF and neglect 
resulting compounds that are predicted as inactive. Then we 
can sort them by the final affinity value predicted by the 
scoring function for such cases and study visually the top ones.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Depiction of the binding mode found by BINDSURF for ligand 
number 17 of the DUD data set of GPB (PDB ID: 1A8I) with pink skeleton 
and crystallographic pose for Beta-D-Glucopyranose Spirohydantoin, with 
green skeleton. 
As an example, we can observe in Figure 4 the good 
agreement in the comparison between the top predicted 
compound from the DUD database for GPB and the 
crystallographic pose. In this case main stabilizing interactions 
are due to a hydrogen-bond network where the intervening 
nitrogen and oxygen atoms of the predicted compound fall very 
close to the same atoms of the crystallographic pose. 
 
IV. CONCLUSIONS 
In this work we have shown how the predictive capability 
of the BINDSURF program can be increased using a neural 
network trained with ligand activity data. It must be mentioned 
that the neural network approach can only be used when there 
is data available for active and non-active compounds for a 
given protein. 
This methodology can be used to improve drug discovery, 
drug design, repurposing and therefore aid considerably in 
clinical research. In the next steps, we want to substitute the 
Monte Carlo minimization algorithm for more efficient 
optimization alternatives, such as the Ant Colony optimization 
method, which we have already efficiently implemented on 
GPU [26] and implement also full ligand and receptor 
flexibility. Lastly, we are also working on improved scoring 
functions to include efficiently metals, aromatic interactions, 
and implicit solvation models. 
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